In April 2025, CMG Pharmaceutical, a subsidiary of CHA Biotech, secured FDA approval for Mezofy (formerly Depipzo), an oral ...

D'Amico AV and Roehrborn CG (2007) Effect of 1 mg/day finasteride on concentrations of serum prostate-specific antigen in men with androgenic alopecia: a randomised controlled trial. Lancet Oncol 8: ...

Federal health regulators say popular weight loss drugs like Wegovy and Zepbound do not increase the risk of suicidal ...

GLP-1 weight-loss pills appear to be just as effective as injections, with clinical trials showing similar average weight ...

Pharmaceutical company Novo Nordisk announced that a new pill-version of its GLP-1 weight-loss drug is now "broadly available ...

The Food and Drug Administration on Tuesday told Eli Lilly and Novo Nordisk to remove warnings about the risk of suicidal ...

The FDA approved oral semaglutide (Wegovy) for weight loss and reducing major adverse cardiovascular events. Novo Nordisk plans to launch the once-daily oral semaglutide in the US in early January ...

Newly-produced examples of the 2026 MG ZS small SUV are now covered by a five-star ANCAP safety rating after an airbag was added between the front seats to prevent head clashes. Hybrid versions of the ...

The Hector continues to be offered in 5-seater and 7-seater options as before, while the 6-seater variants will be reintroduced in 2026 The MG Hector has received a facelift, bringing subtle design ...

The biggest change on the facelifted Hector is up front as previously seen from the leaked image. It now gets a much larger and bolder grille, finished with heavy chrome elements that give it a more ...

Here’s how much the super-rich are really worth Mark Cussen, CMFC, has 13+ years of experience as a writer and provides financial education to military service members and the public. Mark is an ...

Type 1 diabetes (also known as diabetes mellitus) is an autoimmune disease in which immune cells attack and destroy the insulin-producing cells of the pancreas. The loss of insulin leads to the ...